Accendra Health IncACH
Price$0.56

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.6B-1.2% YoYTTM through 30 Jun 2026
Net Income -$302.1MTTM through 30 Jun 2026
Free Cash Flow -$357.2MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin10.8%
Operating Margin1.1%
Net Margin-11.4%

Returns

54.8%ROE
-14.3%ROA
-26.1%ROIC

Balance Sheet Health

Debt / Equity-3.12x
Current Ratio0.41x
Net Debt$1.7B
Cash & Equivalents$7.7M

Quality Metrics

Altman Z-Score0.31
Piotroski F-Score4 / 9
FCF Margin-13.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.8B
Diluted EPS-$3.96TTM
'19'20'21'22'23'24'25
FY2025: $-14.31

Dividend

$0.01Per share, FY20211.41%Yield-52.8%5-yr growth

Capital Allocation

R&D Spend$13M
Capex Intensity6.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.